In this work, we conducted a large cohort case-control study to investigate the promoter methylation changes of two tumor suppressor genes (RASSF1A and ATM) in peripheral blood DNA as potential epigenetic markers for breast cancer risk and early detection. This evidence concerns the gene ATM and breast cancer.